246 related articles for article (PubMed ID: 11469003)
1. [Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].
MMW Fortschr Med; 2001 Jun; 143(25):58. PubMed ID: 11469003
[No Abstract] [Full Text] [Related]
2. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
[No Abstract] [Full Text] [Related]
3. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
Christensen KL
Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
[No Abstract] [Full Text] [Related]
4. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
Zanchetti A
Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
[No Abstract] [Full Text] [Related]
5. Calcium channel blocker.
Li CJ; Shi ZD
Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
[No Abstract] [Full Text] [Related]
6. [Also for problem cases; successful first line therapy].
MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
[No Abstract] [Full Text] [Related]
7. CCBs vs ACE inhibitors in patients with diabetes.
Zamorski MA
J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
[No Abstract] [Full Text] [Related]
8. Calcium antagonists "some agents lower blood pressure and still put the heart at risk"?
Leenen FH
Clin Exp Hypertens; 1999; 21(5-6):823-34. PubMed ID: 10423105
[TBL] [Abstract][Full Text] [Related]
9. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
10. Role of dihydropyridinic calcium channel blockers in the management of hypertension.
Coca A; Mazón P; Aranda P; Redón J; Divisón JA; Martínez J; Calvo C; Galcerán JM; Barrios V; Roca-Cusachs I Coll A
Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):91-105. PubMed ID: 23259449
[TBL] [Abstract][Full Text] [Related]
11. [Dihydropyridines for treatment of arterial hypertension].
Bareza N; Gasser S; Toferer E; Scheer E; Pruthi D; Gasser R
Pharm Unserer Zeit; 2005; 34(5):388-91. PubMed ID: 16180361
[No Abstract] [Full Text] [Related]
12. [Therapy of hypertension with calcium antagonists. Heart and kidney protection for elderly type 2 diabetic patients].
Keil TU
MMW Fortschr Med; 2000 Mar; 142(11):18. PubMed ID: 10786084
[No Abstract] [Full Text] [Related]
13. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
Martinez-Martin FJ; Saiz-Satjes M
Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
15. Newer calcium antagonists for treatment of systemic hypertension.
Singh NK
J Assoc Physicians India; 1995 Apr; 43(4):277-81. PubMed ID: 8713269
[No Abstract] [Full Text] [Related]
16. [Evaluation of lercanidipine in the general practice setting].
Robles NR; Canelada JA; Iglesias M; Angulo E; López Acedo A; Díaz Olea E; Cidoncha F; Guerras M; Fuentes J; Garrido J; Lapie J; Peña J; Aguilar A; Hidalgo P
An Med Interna; 2003 Jun; 20(6):282-6. PubMed ID: 12848597
[TBL] [Abstract][Full Text] [Related]
17. Lercanidipine in hypertension.
Borghi C
Vasc Health Risk Manag; 2005; 1(3):173-82. PubMed ID: 17319103
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers: differences between subclasses.
Frishman WH
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():17-23. PubMed ID: 19845073
[TBL] [Abstract][Full Text] [Related]
19. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Iwasaka T
J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla.
Aota Y; Morimoto S; Sakuma T; Morita T; Jo F; Takahashi N; Maehara M; Ikeda K; Sawada S; Iwasaka T
Hypertens Res; 2009 Aug; 32(8):700-5. PubMed ID: 19521420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]